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Physiology can inform and help transform clinical practice. In
turn, clinical practice demands physiological mechanisms to deter-
mine intervention and treatment. And so the spiral of fresh scientific
discovery and its clinical application goes on.
Lactic acidosis is a common adverse finding in the critically ill
patient. Physiological studies in preclinical animal models have long
established that systemic acidemia can impair cardiovascular func-
tion, weakening cardiac contractility and reducing peripheral vascu-
lar reactivity to constrictor agonists [1]. However, underlying
mechanisms have not been delineated, particularly in humans. Of
greater importance, no human clinical trial until the work by Rodri-
gez-Villar et al. published in this issue of EClinicalMedicine [2] had
established a threshold arterial pH, below which cardiac function
becomes compromised. This commendable and difficult-to-execute
study not only confirms a negative relationship between arterial pH
and cardiac dysfunction in humans, but it demands questions with
potential answers that have the power to transform the clinical man-
agement of patients with severe acidemia, such as those suffering
from septic shock or cardiac arrest. What is so critical about a thresh-
old arterial pH of 7.28 below which cardiac function deteriorates?
What is the underlying physiological mechanism linking acidemia
and cardiac dysfunction in humans? Is acidemia a cause or effect of
cardiac dysfunction in critically ill men and women? Can respiratory
versus metabolic acidosis differentially affect cardiac function? What
is the best therapy for normalising pH and is there a statistical rela-
tionship between buffering pH and improved cardiac function in the
ICU patient?DOI of original article: http://dx.doi.org/10.1016/j.eclinm.2021.100956.
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birth has also been an area of intense scientific interest for many years,
largely because it is a common outcome of labour and delivery [3]. Dur-
ing labour, compression of the umbilical cord can lead to fetal hypoxia
and trigger a carotid chemoreflex that reduces heart rate and redistrib-
utes cardiac output away from peripheral circulations towards the fetal
brain, the so-called fetal brain sparing response [4,5]. Lactic acidemia in
the fetus results from the anaerobic metabolism of glucose in tissues,
particularly in those undergoing peripheral vasoconstriction as a result
of the fetal brain-sparing reflex [6]. A study in late gestation, mature,
fetal sheep showed that acidemia enhanced the magnitude of the fetal
cardiovascular and endocrine defences to acute stress, but it reversed
the increase in umbilical vascular conductance to vasoconstriction, dur-
ing an episode of acute hypoxia. Therefore, it is clear that acidemia in
fetal as well as adult life can significantly impact cardiovascular func-
tion, however underlying mechanisms remain to be fully explored. It is
also clear that, whether in fetal or adult life, acidemia rarely occurs in
isolation, often being accompanied by altered arterial blood gas status
and increased levels of stress hormones in the circulation. If this is the
case, then how can the clinician detect incipient cardiac decompensa-
tion either during complicated labour in the fetus or in the ICU setting
in the critically ill to offer life-saving interventions such as ECMO [7]?
This challenge has been tackled recently in preclinical studies where a
machine learning algorithm leveraging continuous heart rate data has
enabled more precise, individualized medicine with real-time predic-
tion of cardiovascular decompensation [8].
Interestingly, the study of Rodrigez-Villar et al. does not present real-
time cardiovascular data in the patients, such as the electrocardiogram
(ECG) and arterial blood pressure (ABP), because these cardiovascular
outcomes were not accessible to the researchers. This can no longer be
the status quo in 21st century medicine. Hospitals spend considerable
resources to be able to afford real-time monitoring of such indispens-
able physiological data in the ICU setting. Patients enrolled in the study
have the right to these data, yet clinicians are often unable to access the
raw data to conduct the critical clinical analysis. In light of the growing
mass of evidence that unequivocally supports that access to such data
can transform clinical care, this situation needs to change. Access to ECG
and ABP in-depth data analysis would enable the development of real-
time prediction of cardiovascular decompensation. In turn, this would
lead to earlier interventions, reducing morbidity and mortality. There-
fore, we call upon themanufacturers of the clinical ICUmonitoring devi-
ces to remove their silos around accessing cardiovascular raw data.
Doing so would boost badly needed clinical research and algorithmC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
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